Request for Covid-19 Impact Assessment of this Report
In the last several years, Global market of Mitomycin C was experienced an upward trend rapidly, with an average growth rate of 4.76%. In 2016, Global Revenue of Mitomycin C is nearly 119.83 M USD; the actual production is about 17370 K Unit.
The major players in global Mitomycin C market include
Kyowa-kirin
Intas Pharmaceuticals
Teva
Bristol-Myers Squibb
Aspen
Speciality European Pharma
Alkem Laboratories
Varifarma
APOGEPHA
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Mitomycin C in these regions, from 2012 to 2022 (forecast), covering
Europe
North America
India
Japan
Other
On the basis of product, the Mitomycin C market is primarily split into
2 Mg
10 Mg
40 Mg
Other
On the basis on the end users/applications, this report covers
Cancer Treatment
Ophthalmic Use
Others
1 Mitomycin C Market Overview 1
1.1 Product Overview and Scope of Mitomycin C 1
1.2 Mitomycin C Segment by Types 2
1.2.1 Mitomycin C Segment by Types 2
1.2.2 Global Mitomycin C Production Market Share by Types in 2016 2
1.2.3 2 Mg 3
1.2.4 10 Mg 3
1.2.5 40 Mg 4
1.3 Global Mitomycin C Segment by Applications 4
1.3.1 Global Mitomycin C Segment by Applications 4
1.3.2 Cancer Treatment 5
1.3.3 Ophthalmic Use 6
1.4 Global Mitomycin C Market by Regions (2012-2022) 7
1.4.1 North America Mitomycin C Status and Prospect (2012-2022) 7
1.4.2 India Mitomycin C Status and Prospect (2012-2022) 8
1.4.3 Europe Mitomycin C Status and Prospect (2012-2022) . 8
1.4.4 Japan Mitomycin C Status and Prospect (2012-2022) 9
1.5 Global Mitomycin C Market Size (2012-2022) 10
1.5.1 Global Mitomycin C Revenue Status and Outlook (2012-2022) 10
1.5.2 Global Mitomycin C Production Status and Outlook (2012-2022) 11
2 Global Mitomycin C Market Competition by Manufacturers 12
2.1 Global Mitomycin C Production and Share by Manufacturers (2016-2017) 12
2.2 Global Mitomycin C Revenue and Share by Manufacturers (2016-2017) 14
2.3 Global Mitomycin C Average Price by Manufacturers (2016-2017) 16
2.4 Manufacturers Mitomycin C Headquarters and Establish Date 17
2.5 Mitomycin C Market Competitive Situation and Trends 17
2.5.1 Mitomycin C Market Concentration Rate 17
2.5.2 Mitomycin C Market Share of Top 3 and Top 5 Manufacturers 18
2.5.3 Mergers & Acquisitions, Expansion 19
3 Global Mitomycin C Production by Regions (2012-2017) 20
3.1 Global Mitomycin C Production and Market Share by Regions (2012-2017) 20
3.2 Global Mitomycin C Revenue and Market Share by Regions (2012-2017) 22
3.3 Global Mitomycin C Production Revenue, Price and Gross Margin (2012-2017) 24
3.4 North America Mitomycin C Production (2012-2017) 25
3.4.1 North America Mitomycin C Production and Growth Rate (2012-2017) 25
3.4.2 North America Mitomycin C Production, Revenue, Price and Gross Margin (2012-2017) 25
3.5 Europe Mitomycin C Production (2012-2017) 26
3.5.1 Europe Mitomycin C Production and Growth Rate (2012-2017) 26
3.5.2 Europe Mitomycin C Production, Revenue, Price and Gross Margin (2012-2017) 26
3.6 India Mitomycin C Production (2012-2017) 27
3.6.1 India Mitomycin C Production and Growth Rate (2012-2017) 27
3.6.2 India Mitomycin C Production, Revenue, Price and Gross Margin (2012-2017) 27
3.7 Japan Mitomycin C Production (2012-2017) 28
3.7.1 Japan Mitomycin C Production and Growth Rate (2012-2017) 28
3.7.2 Japan Mitomycin C Production, Revenue, Price and Gross Margin (2012-2017) 28
4 Global Mitomycin C Consumption (K Unit) by Regions (2012-2017) 30
4.1 Global Mitomycin C Consumption by Regions (2012-2017) 30
4.2 North America Mitomycin C Consumption (2012-2017) 32
4.3 Europe Mitomycin C Consumption (2012-2017) 33
4.4 China Mitomycin C Consumption (2012-2017) 33
4.5 Japan Mitomycin C Consumption (2012-2017) 34
4.6 India Mitomycin C Consumption (2012-2017) 34
5 Global Mitomycin C Production, Revenue, Price Trend by Types 35
5.1 Global Mitomycin C Production and Market Share by Types (2012-2017) 35
5.2 Global Mitomycin C Revenue and Market Share by Types (2012-2017) 37
5.3 Global Mitomycin C Price by Type (2012-2017) 38
5.4 Global Mitomycin C Production Growth by Type (2012-2017) 39
6 Global Mitomycin C Market Analysis by Applications 40
6.1 Global Mitomycin C Consumption and Market Share by Applications (2012-2017) 40
6.2 Global Mitomycin C Consumption Growth Rate by Applications (2012-2017) 42
7 Analysis of Mitomycin C Industry Key Manufacturers 43
7.1 Kyowa-kirin 43
7.1.1 Company Profile 43
7.1.2 Product Information 44
7.1.3 Production, Price, Cost, Gross, and Revenue 44
7.2 Intas Pharmaceuticals 45
7.2.1 Company Profile 45
7.2.2 Product Information 47
7.2.3 Production, Price, Cost, Gross, and Revenue 47
7.3 Teva 48
7.3.1 Company Profile 48
7.3.2 Product Information 49
7.3.3 Production, Price, Cost, Gross, and Revenue 49
7.4 Bristol-Myers Squibb 50
7.4.1 Company Profile 50
7.4.2 Product Information 51
7.4.3 Production, Price, Cost, Gross, and Revenue 51
7.5 Aspen 52
7.5.1 Company Profile 52
7.5.2 Product Information 53
7.5.3 Production, Price, Cost, Gross, and Revenue 53
7.6 Speciality European Pharma 54
7.6.1 Company Profile 54
7.6.2 Product Information 55
7.6.3 Production, Price, Cost, Gross, and Revenue 55
7.7 Alkem Laboratories 56
7.7.1 Company Profile 56
7.7.2 Product Information 57
7.7.3 Production, Price, Cost, Gross, and Revenue 57
7.8 Varifarma 58
7.8.1 Company Profile 58
7.8.2 Product Information 59
7.8.3 Production, Price, Cost, Gross, and Revenue 59
7.9 APOGEPHA 59
7.9.1 Company Profile 59
7.9.2 Product Information 61
7.9.3 Production, Price, Cost, Gross, and Revenue 61
8 Mitomycin C Manufacturing Cost Analysis 62
8.1 Mitomycin C Key Raw Materials Analysis 62
8.1.1 Key Raw Materials 62
8.1.2 Key Suppliers of Raw Materials 62
8.2 Proportion of Manufacturing Cost Structure 64
8.2.1 Raw Materials 64
8.2.2 Labor Cost 64
8.2.3 Manufacturing Expenses 69
8.3 Manufacturing Process Analysis of Mitomycin C 69
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 70
9.1 Mitomycin C Industrial Chain Analysis 70
9.2 Upstream Raw Materials Sourcing 71
9.3 Downstream Buyers 71
10 Marketing Strategy Analysis, Distributors/Traders 74
10.1 Marketing Channel 74
10.1.1 Direct Marketing 74
10.1.2 Indirect Marketing 74
10.1.3 Marketing Channel Development Trend 74
10.2 Market Positioning 75
10.2.1 Pricing Strategy 75
10.2.2 Brand Strategy 76
10.2.3 Target Client 77
10.3 Distributors/Traders List 78
11 Market Effect Factors Analysis 80
11.1 Technology Progress/Risk 80
11.1.1 Substitutes Threat 80
11.1.2 Technology Progress in Related Industry 82
11.2 Consumer Needs/Customer Preference Change 85
11.3 Economic/Political Environmental Change 86
12 Global Mitomycin C Market Forecast (2017-2022) 94
12.1 Global Mitomycin C Production, Revenue Forecast (2017-2022) 94
12.1.1 Global Mitomycin C Production and Growth Rate Forecast (2017-2022) 94
12.1.2 Global Mitomycin C Revenue and Growth Rate Forecast (2017-2022) 95
12.1.3 Global Mitomycin C Price and Trend Forecast (2017-2022) 96
12.2 Global Mitomycin C Production Forecast by Regions (2017-2022) 96
12.3 Global Mitomycin C Consumption Forecast by Regions (2017-2022) 97
12.3.1 North America Mitomycin C Consumption Forecast (2017-2022) 98
12.3.2 Europe Mitomycin C Consumption Forecast (2017-2022) 99
12.3.3 China Mitomycin C Consumption Forecast (2017-2022) 100
12.3.4 Japan Mitomycin C Consumption Forecast (2017-2022) 101
12.3.5 India Mitomycin C Consumption Forecast (2017-2022) 102
12.4 Global Mitomycin C Production and Revenue Forecast by Type (2017-2022) 102
12.5 Global Mitomycin C Consumption Forecast by Application (2017-2022) 104
13 Research Findings and Conclusion 106
14 Methodology and Data Source 107
14.1 Methodology/Research Approach 107
14.1.1 Research Programs/Design 107
14.1.2 Market Size Estimation 108
14.2 Data Source 110
14.2.1 Secondary Sources 110
14.2.2 Primary Sources 111
14.3 Disclaimer 112
14.4 Author List 113
Figure Product Picture of Mitomycin C 1
Table Mitomycin C Segment by Types 2
Figure Global Mitomycin C Production Market Share by Types in 2016 2
Figure Product Picture of 2 Mg 3
Figure Product Picture of 10 Mg 3
Figure Product Picture of 40 Mg 4
Table Global Mitomycin C Segment by Applications 4
Figure Global Mitomycin C Consumption (K Unit) Market Share by Applications in 2016 5
Figure Cancer Treatment Examples 5
Figure Ophthalmic Use Examples 6
Figure North America Mitomycin C Revenue (M USD) and Growth Rate (2012-2022) 7
Figure India Mitomycin C Revenue (M USD) and Growth Rate (2012-2022) 8
Figure Europe Mitomycin C Revenue (M USD) and Growth Rate (2012-2022) 8
Figure Japan Mitomycin C Revenue (M USD) and Growth Rate (2012-2022) 9
Figure Global Mitomycin C Revenue Status and Outlook (2012-2022) 10
Figure Global Mitomycin C Production Status and Outlook (2012-2022) 11
Table Global Mitomycin C Production (K Unit) of Key Manufacturers (2016-2017) 12
Table Global Mitomycin C Production Share by Manufacturers (2016-2017) 12
Figure 2016 Mitomycin C Production Share by Manufacturers 13
Figure 2017 Mitomycin C Production Share by Manufacturers 13
Table Global Mitomycin C Revenue (M USD) by Manufacturers (2016-2017) 14
Table Global Mitomycin C Revenue Share by Manufacturers (2016-2017) 14
Figure 2016 Global Mitomycin C Revenue Share by Manufacturers 15
Figure 2017 Global Mitomycin C Revenue Share by Manufacturers 15
Table Global Market Mitomycin C Average Price (USD/Unit) of Key Manufacturers (2016-2017) 16
Figure Global Market Mitomycin C Average Price (USD/Unit) of Key Manufacturers in 2016 16
Table Manufacturers Mitomycin C Headquarters and Establish Date 17
Table Global Mitomycin C Production Share by Manufacturers (2016-2017) 17
Figure Mitomycin C Production Market Share of Top 3 Manufacturers 18
Figure Mitomycin C Production Market Share of Top 5 Manufacturers 18
Table Global Mitomycin C Production (K Unit) by Regions (2012-2017) 20
Table Global Mitomycin C Production Market Share by Regions (2012-2017) 20
Figure Global Mitomycin C Production Market Share by Regions (2012-2017) 21
Figure 2016 Global Mitomycin C Production Market Share by Regions 21
Table Global Mitomycin C Revenue (M USD) by Regions (2012-2017) 22
Table Global Mitomycin C Revenue Market Share by Regions (2012-2017) 22
Figure Global Mitomycin C Revenue Market Share by Regions (2012-2017) 22
Figure 2016 Global Mitomycin C Revenue Market Share by Regions 23
Figure Global Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 24
Table Global Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 24
Figure North America Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 25
Table North America Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 25
Figure Europe Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 26
Table Europe Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 26
Figure India Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 27
Table India Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 27
Figure Japan Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 28
Table Japan Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 28
Table Global Mitomycin C Consumption (K Unit) Market by Regions (2012-2017) 30
Table Global Mitomycin C Consumption Market Share by Regions (2012-2017) 30
Figure Global Mitomycin C Consumption Market Share by Regions (2012-2017) 31
Figure 2016 Global Mitomycin C Consumption Market Share by Regions 31
Figure North America Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 32
Figure Europe Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 33
Figure China Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 33
Figure Japan Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 34
Figure India Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 34
Table Global Mitomycin C Production (K Unit) by Types (2012-2017) 35
Table Global Mitomycin C Production Share by Types (2012-2017) 35
Figure Production Market Share of Mitomycin C by Types (2012-2017) 36
Figure 2016 Production Market Share of Mitomycin C by Types 36
Table Global Mitomycin C Revenue (M USD) by Types (2012-2017) 37
Table Global Mitomycin C Revenue Share by Types (2012-2017) 37
Figure Revenue Share of Mitomycin C by Types (2012-2017) 37
Figure 2016 Revenue Market Share of Mitomycin C by Types 38
Table Global Mitomycin C Price (USD/Unit) by Types (2012-2017) 38
Figure Global Mitomycin C Production Growth by Type (2012-2017) 39
Table Global Mitomycin C Consumption (K Unit) by Applications (2012-2017) 40
Table Global Mitomycin C Consumption Market Share by Applications (2012-2017) 40
Figure Global Mitomycin C Consumption Market Share by Applications (2012-2017) 41
Figure Global Mitomycin C Consumption Market Share by Applications in 2016 41
Table Global Mitomycin C Consumption Growth Rate by Applications (2012-2017) 42
Figure Global Mitomycin C Consumption Growth Rate by Applications (2012-2017) 42
Table Kyowa-kirin Company Profile 43
Figure Mitomycin C Product Picture of Kyowa-kirin 44
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Kyowa-kirin 2016-2017 44
Table Intas Pharmaceuticals Company Profile 45
Figure Mitomycin C Product Picture of Intas Pharmaceuticals 47
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Intas Pharmaceuticals 2016-2017 47
Table Teva Company Profile 48
Figure Mitomycin C Product Picture of Teva 49
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2016-2017 49
Table Bristol-Myers Squibb Company Profile 50
Figure Mitomycin C Product Picture of Bristol-Myers Squibb 51
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2016-2017 51
Table Aspen Company Profile 52
Figure Mitomycin C Product Picture of Aspen 53
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aspen 2016-2017 53
Table Speciality European Pharma Company Profile 54
Figure Mitomycin C Product Picture of Speciality European Pharma 55
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Speciality European Pharma 2016-2017 55
Table Alkem Laboratories Company Profile 56
Figure Mitomycin C Product Picture of Alkem Laboratories 57
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alkem Laboratories 2016-2017 57
Table Varifarma Company Profile 58
Figure Mitomycin C Product Picture of Varifarma 59
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Varifarma 2016-2017 59
Table APOGEPHA Company Profile 59
Figure Mitomycin C Product Picture of APOGEPHA 61
Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of APOGEPHA 2016-2017 61
Table Key Raw Materials 62
Table Key Suppliers of Raw Materials 62
Figure Manufacturing Cost Structure of Mitomycin C 64
Figure USA Labor Cost Analysis 2012-2016 65
Figure Cost of Employing a Factory Worker 66
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe 67
Figure Monthly Minimum Wages in Asia 2016 68
Figure China Labor Costs 2013-2016 68
Figure Manufacturing Process Analysis of Mitomycin C 69
Figure Mitomycin C Industrial Chain Analysis 70
Table Major Buyers of Mitomycin C 71
Figure Setting Pricing Policy 75
Table Distributors/Traders List 78
Figure Growth of the Late Phase Oncology Pipeline, 2005-2015 82
Figure Key In-Market and Investigational Agents for NSCLC 83
Figure Key In-Market and Investigational Agents for Melanoma 83
Figure the Global Late Phase Oncology Pipeline in 2015 84
Figure Companies with Active Late Phase Oncology Pipelines 85
Figure Global GDP Growth Rate for 2016 86
Figure US GDP 2006-2016 (Billion USD) 87
Figure US CPI Change 2016-2017 87
Figure EU GDP 2006-2016 (Billion USD) 88
Figure EU CPI Change 2012-2016 88
Figure Germany GDP 2006-2016 (Billion USD) 89
Figure UK GDP 2006-2016 (Billion USD) 89
Figure UK CPI Change 2016-2017 90
Figure Italy GDP 2006-2016 (Billion USD) 90
Figure Italy CPI Change 2016-2017 91
Figure Japan GDP 2006-2016 (Billion USD) 91
Figure Japan CPI Change 2012-2016 92
Figure China GDP 2006-2016 (Billion USD) 92
Figure China CPI Change 2016-2017 93
Figure Global Mitomycin C Production (K Unit) and Growth Rate Forecast (2017-2022) 94
Figure Global Mitomycin C Revenue (M USD) and Growth Rate Forecast (2017-2022) 95
Figure Global Mitomycin C Price (USD/Unit) and Trend Forecast (2017-2022) 96
Table Global Mitomycin C Production (K Unit) Forecast by Regions (2017-2022) 96
Figure Global Mitomycin C Production Market Share Forecast by Regions (2017-2022) 97
Table Global Mitomycin C Consumption (K Unit) Forecast by Regions (2017-2022) 97
Figure Global Mitomycin C Consumption Market Share Forecast by Regions (2017-2022) 98
Figure North America Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 98
Figure Europe Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 99
Figure China Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 100
Figure Japan Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 101
Figure India Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 102
Table Global Mitomycin C Production (K Unit) Forecast by Type (2017-2022) 102
Figure Global Mitomycin C Production Forecast by Type (2017-2022) 103
Table Global Mitomycin C Revenue (M USD) Forecast by Type (2017-2022) 103
Figure Global Mitomycin C Revenue Market Share Forecast by Type (2017-2022) 104
Table Global Mitomycin C Consumption (K Unit) Forecast by Application (2017-2022) 104
Figure Global Mitomycin C Consumption Forecast by Application (2017-2022) 105
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...